Guidelines for the understanding and management of pain in chronic pancreatitis
Asbjørn Mohr Drewes(Aalborg University Hospital), Dhiraj Yadav(Sarguja University), Stefan A.W. Bouwense(Radboud University Medical Center), David C. Whitcomb(Christian Medical College & Hospital), Søren Schou Olesen(Aalborg University Hospital), Tooru Shimosegawa(Japan Pancreatic Disease Research Foundation), Pramod Kumar Garg(All India Institute of Medical Sciences), Myriam Delhaye(Erasmus Hospital), Harry van Goor(Radboud University Nijmegen), Andrea Sheel(University of Liverpool), John P. Neoptolemos(University of Liverpool), Tonya M. Palermo(Seattle Children's Hospital), Eva Szigethy(University of Pittsburgh Medical Center), Claudia M. Campbell(Johns Hopkins Medicine), Christopher Halloran(University of Liverpool), İhsan Ekin Demir(TUM Klinikum), Güralp O. Ceyhan(TUM Klinikum), Shuiji Isaji(Mie University), Pankaj J. Pasricha(Mayo Clinic in Arizona)
Cited by 313
Related Papers
Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial
|The Lancet|2017|1.9k
Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene
|Nature Genetics|1996|1.6k
Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid vs Gemcitabine Following Pancreatic Cancer Resection
|JAMA|2010|1.4k
Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study
|The Lancet Oncology|2019|1.2k
Chronic pancreatitis: Diagnosis, classification, and new genetic developments
|Gastroenterology|2001|1.2k